A detailed history of Readystate Asset Management LP transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Readystate Asset Management LP holds 113,823 shares of KROS stock, worth $6.61 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
113,823
Previous 94,373 20.61%
Holding current value
$6.61 Million
Previous $6.25 Billion 16.74%
% of portfolio
0.17%
Previous 0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$44.58 - $66.89 $867,081 - $1.3 Million
19,450 Added 20.61%
113,823 $5.2 Billion
Q1 2024

May 10, 2024

BUY
$41.26 - $70.48 $3.89 Million - $6.65 Million
94,373 New
94,373 $6.25 Billion

Others Institutions Holding KROS

About Keros Therapeutics, Inc.


  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $1.49B
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Readystate Asset Management LP Portfolio

Follow Readystate Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Readystate Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Readystate Asset Management LP with notifications on news.